Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 158

1.

Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.

Regalado-Reyes M, Furcila D, Hernández F, Ávila J, DeFelipe J, León-Espinosa G.

J Alzheimers Dis. 2019;69(1):277-288. doi: 10.3233/JAD-181263.

PMID:
30958368
2.

GSK3β overexpression driven by GFAP promoter improves rotarod performance.

Jurado-Arjona J, Rodríguez-Matellán A, Ávila J, Hernández F.

Brain Res. 2019 Jun 1;1712:47-54. doi: 10.1016/j.brainres.2019.01.040. Epub 2019 Jan 31.

PMID:
30711399
3.

Profiling of Argonaute-2-loaded microRNAs in a mouse model of frontotemporal dementia with parkinsonism-17.

Kenny A, Hernández F, Avila J, Lucas JJ, Henshall DC, Prehn JH, Jiménez-Mateos EM, Engel T.

Int J Physiol Pathophysiol Pharmacol. 2018 Dec 25;10(6):172-183. eCollection 2018.

4.

Peripheral nervous system effects in the PS19 tau transgenic mouse model of tauopathy.

Merchán-Rubira J, Sebastián-Serrano Á, Díaz-Hernández M, Avila J, Hernández F.

Neurosci Lett. 2019 Apr 17;698:204-208. doi: 10.1016/j.neulet.2019.01.031. Epub 2019 Jan 21.

PMID:
30677432
5.

Role of tau N-terminal motif in the secretion of human tau by End Binding proteins.

Sayas CL, Medina M, Cuadros R, Ollá I, García E, Pérez M, Ferrer I, Hernández F, Avila J.

PLoS One. 2019 Jan 22;14(1):e0210864. doi: 10.1371/journal.pone.0210864. eCollection 2019.

6.

MicroRNA-22 Controls Aberrant Neurogenesis and Changes in Neuronal Morphology After Status Epilepticus.

Beamer EH, Jurado-Arjona J, Jimenez-Mateos EM, Morgan J, Reschke CR, Kenny A, de Leo G, Olivos-Oré LA, Arribas-Blázquez M, Madden SF, Merchán-Rubira J, Delanty N, Farrell MA, O'Brien DF, Avila J, Diaz-Hernandez M, Miras-Portugal MT, Artalejo AR, Hernandez F, Henshall DC, Engel T.

Front Mol Neurosci. 2018 Dec 11;11:442. doi: 10.3389/fnmol.2018.00442. eCollection 2018.

7.

Human Brain Single Nucleotide Polymorphism: Validation of DNA Sequencing.

Picher ÁJ, Hernández F, Budeus B, Soriano E, Avila J.

J Alzheimers Dis Rep. 2018 May 31;2(1):103-109. doi: 10.3233/ADR-170039. Review.

8.

Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus.

Engel T, Gómez-Sintes R, Alves M, Jimenez-Mateos EM, Fernández-Nogales M, Sanz-Rodriguez A, Morgan J, Beamer E, Rodríguez-Matellán A, Dunleavy M, Sano T, Avila J, Medina M, Hernandez F, Lucas JJ, Henshall DC.

Cell Death Dis. 2018 Sep 20;9(10):969. doi: 10.1038/s41419-018-0963-5.

9.

Frontotemporal Dementia-Associated N279K Tau Mutation Localizes at the Nuclear Compartment.

Ritter ML, Avila J, García-Escudero V, Hernández F, Pérez M.

Front Cell Neurosci. 2018 Jul 12;12:202. doi: 10.3389/fncel.2018.00202. eCollection 2018.

10.

New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy.

Hernández F, Llorens-Martín M, Bolós M, Pérez M, Cuadros R, Pallas-Bazarra N, Zabala JC, Avila J.

J Alzheimers Dis. 2018;64(s1):S529-S534. doi: 10.3233/JAD-179916.

PMID:
29562521
11.

Secretion of full-length Tau or Tau fragments in cell culture models. Propagation of Tau in vivo and in vitro.

Pérez M, Medina M, Hernández F, Avila J.

Biomol Concepts. 2018 Mar 5;9(1):1-11. doi: 10.1515/bmc-2018-0001. Review.

PMID:
29509544
12.

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.

Fuster-Matanzo A, Hernández F, Ávila J.

Int J Mol Sci. 2018 Feb 25;19(3). pii: E645. doi: 10.3390/ijms19030645. Review.

13.

Author Correction: Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.

Pose-Utrilla J, García-Guerra L, Del Puerto A, Martín A, Jurado-Arjona J, De León-Reyes NS, Gamir-Morralla A, Sebastián-Serrano Á, García-Gallo M, Kremer L, Fielitz J, Ireson C, Pérez-Álvarez MJ, Ferrer I, Hernández F, Ávila J, Lasa M, Campanero MR, Iglesias T.

Nat Commun. 2018 Jan 30;9(1):473. doi: 10.1038/s41467-018-03022-4.

14.

Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1.

Pose-Utrilla J, García-Guerra L, Del Puerto A, Martín A, Jurado-Arjona J, De León-Reyes NS, Gamir-Morralla A, Sebastián-Serrano Á, García-Gallo M, Kremer L, Fielitz J, Ireson C, Pérez-Álvarez MJ, Ferrer I, Hernández F, Ávila J, Lasa M, Campanero MR, Iglesias T.

Nat Commun. 2017 Dec 22;8(1):2275. doi: 10.1038/s41467-017-02322-5. Erratum in: Nat Commun. 2018 Jan 30;9(1):473.

15.

Cognitive Decline in Neuronal Aging and Alzheimer's Disease: Role of NMDA Receptors and Associated Proteins.

Avila J, Llorens-Martín M, Pallas-Bazarra N, Bolós M, Perea JR, Rodríguez-Matellán A, Hernández F.

Front Neurosci. 2017 Nov 10;11:626. doi: 10.3389/fnins.2017.00626. eCollection 2017. Review.

16.

Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.

Antón-Fernández A, Merchán-Rubira J, Avila J, Hernández F, DeFelipe J, Muñoz A.

J Alzheimers Dis. 2017;60(2):651-661. doi: 10.3233/JAD-170332.

17.

Absence of CX3CR1 impairs the internalization of Tau by microglia.

Bolós M, Llorens-Martín M, Perea JR, Jurado-Arjona J, Rábano A, Hernández F, Avila J.

Mol Neurodegener. 2017 Aug 15;12(1):59. doi: 10.1186/s13024-017-0200-1.

18.

Commentary: Genome-wide association study identifies 74 loci associated with educational attainment.

Hernández F, Ávila J.

Front Mol Neurosci. 2017 Jan 31;10:23. doi: 10.3389/fnmol.2017.00023. eCollection 2017. No abstract available.

19.

Validation of Suspected Somatic Single Nucleotide Variations in the Brain of Alzheimer's Disease Patients.

Gomez-Ramos A, Picher AJ, García E, Garrido P, Hernandez F, Soriano E, Avila J.

J Alzheimers Dis. 2017;56(3):977-990. doi: 10.3233/JAD-161053.

20.

Tau Structures.

Avila J, Jiménez JS, Sayas CL, Bolós M, Zabala JC, Rivas G, Hernández F.

Front Aging Neurosci. 2016 Nov 8;8:262. eCollection 2016. Review.

Supplemental Content

Loading ...
Support Center